Lixte Biotechnology Holdings's total assets for Q1 2025 were $1.51M, an increase of 32.19% from the previous quarter. LIXT total liabilities were $355.10K for the fiscal quarter, a 11.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.